Year 2008,
Volume: 21 Issue: 2, 127 - 132, 24.06.2015
Abstract
-
Keywords
References
- Abrams P, Cardozo L, Fall M, et al. The standardization
- of terminology of lower urinary tract function: report
- from the Standardization Subcommittee of the
- International Continence Society. Neurourol Urodyn
- : 21: 167-178.
- Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J,
- Wein AJ. How widespread are the symptoms of an
- overactive bladder and how are they managed? A
- population based prevalence study. BJU Int 2001: 87:
- -766.
- Milson I, Stewart W, Thuroff J. The prevalence of
- overactive bladder. Am J Manag Care 6 (Suppl. 11)
- : S565-5573
- Yoshimura N, de Groat WC. Neural control of lower
- urinary tract. Int J Urol 1997: 4: 111-125.
- De Groat WC. A neurologic basis for the overactive
- bladder. Urology suppl. 1997: 50: 36-52.
- Wang P, Luthin GR, Ruggieri MR. Muscarinic
- acetylcholine receptor subtypes mediating urinary
- bladder contractility and coupling to GTP binding
- proteins. J Pharmacol Exp Ther 1995: 273: 959-966.
- Yoshimura N, Chancellor MB. Current and future
- pharmacological treatment for overactive bladder. J Urol
- : 168:1897-1913.
- Wein AJ. Neuromuscular dysfunction of lower urinary
- tract and its management. In: Walsh PC, Retik AB,
- Darracot Vaughan jr. E, Wein AJ (eds) Campell’s
- Urology. Saunders, Philadelphia, 2002: 931-1026.
- Madersbacher H, Rovner E. Trospium chloride: the
- European experience. Expert Opin Pharmacother 2006:
- :1373-1380.
- Hofner K, Oelke M, Machtens S, Grunewald T.
- Trospium chloride an effective drug in the treatment of
- overactive bladder and detrusor hyperreflexia. World J
- Urol 2001: 19: 336-343.
- Guay DR. Clinical pharmacokinetics of drugs used to
- treat urge incontinence. Clin Pharmacokinet 1986: 42:
- -1285.
- Vereecken RL. A critical view on the value of
- urodynamics in non neurogenic incontinence in women.
- Int Urogynecol J 2000: 11: 188-195.
- Coyne KS, Zyczynski T, Margolis MK, Elinof V,
- Roberts RG. Validation of an overactive bladder
- awareness tool for use in primary care settings. Adv
- Ther 2005: 22: 381-394.
- Hu TW, Wagner TH, Bentkover JD, et al. Estimated
- economic cost of overactive bladder in the United
- States. Urology 2003: 61: 1123-1128.
- Abrams P, Anderson KE. Muscarinic receptor
- anragonists for overactive bladder. BTU Int 2007: 100:
- -1006.
- Zinner M, Gittelman M, Haris R, et al. Trospium
- chloride improves bladder symptoms. A multicenter
- phase III trial. J Urol 2004:171: 2311-2315.
- Rudy D, Cline K, Harris R, et al.Multicenter phase III
- trial studying trospium chloride in patients with over
- active bladder. Urology 2006; 67:275-280.
- Halaska M, Ralph G, Wiedeman A, et al. Controlled,
- double-blind, multicenter clinical trial to investigate
- long-term tolerability and efficacy of trospium chloride
- in patients with detrusor instability. World J Urol 2002:
- : 392-399.
- Flisser A, Walmsey K, Blavias JG. Urodynamics
- classification of patients with symptoms of overactive
- bladder. J Urol 2003: 169: 529-533.
- Lin LY, Yeh NH, Lin CY, Sheu BC, Lin HH.
- Comparisons of urodynamic characteristics between
- female patients with overactive bladder and overactive
- bladder plus stress urinary incontinence. Urology 2004:
- : 945-949.
- Digesu GA, Khullar V, Cardozo L, Stefano S.
- Overactive bladder symptoms: Do we need
- urodynamics? Neurourol Urodyn 2003: 22: 105-108.
- Ouslander JG. Management of overactive bladder. N
- Engl J Med 2004: 350: 786-799.
- Staskin DR, Wein AJ, Andersson KE, et al. Overview
- consensus statement. Urology 2003: 61: 1128-8.
- Alloussi S, Laval KU, Eckert R, et al. Trospium chloride
- in patients with motor urge symptoms: A double blind,
- randomised, multicentre, placebo controlled study. J
- Drug Asses 1999: 2: 27-39.
Year 2008,
Volume: 21 Issue: 2, 127 - 132, 24.06.2015
Abstract
Amaç: Aşırı aktif mesane sendromu bulunan kadınlarda trospium tedavisinin etkinliği ve bu etkinin ürodinamik bulgular ile ilişkisi araştırıldı. Yöntem: Aşırı aktif mesane sendromu bulunan 44 kadın hasta çalışmaya alındı. 8 haftalık trospiyum tedavisinden sonra, hastaların tedavi öncesi ve sonrası OAB-V8 semptom skoru, ürodinamik bulguları karşılaştırıldı. Bulgular: Ortalama OAB-V8 semptom skoru tedavi ile birlikte anlamlı olarak düşük bulundu (11.9±6.3; 24.9±5.1; p<0.05).Detrusor aşırı aktivitesi bulunan kadın hastaların (10.3±4.1) detrusor aşırı aktivitesi olmayan kadın hastalara (14.2+5.3) göre trospium tedavisinden daha fazla fayda gördükleri saptandı. Sonuç: Trospium tedavisi ispatlanmış detrusor aşırı aktivitesi olan kadın hastalarda daha etkili bulunmuştur. Anahtar Kelimeler: Aşırı aktif mesane, İşeme disfonksiyonu, Farmakoterapi
Keywords
References
- Abrams P, Cardozo L, Fall M, et al. The standardization
- of terminology of lower urinary tract function: report
- from the Standardization Subcommittee of the
- International Continence Society. Neurourol Urodyn
- : 21: 167-178.
- Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J,
- Wein AJ. How widespread are the symptoms of an
- overactive bladder and how are they managed? A
- population based prevalence study. BJU Int 2001: 87:
- -766.
- Milson I, Stewart W, Thuroff J. The prevalence of
- overactive bladder. Am J Manag Care 6 (Suppl. 11)
- : S565-5573
- Yoshimura N, de Groat WC. Neural control of lower
- urinary tract. Int J Urol 1997: 4: 111-125.
- De Groat WC. A neurologic basis for the overactive
- bladder. Urology suppl. 1997: 50: 36-52.
- Wang P, Luthin GR, Ruggieri MR. Muscarinic
- acetylcholine receptor subtypes mediating urinary
- bladder contractility and coupling to GTP binding
- proteins. J Pharmacol Exp Ther 1995: 273: 959-966.
- Yoshimura N, Chancellor MB. Current and future
- pharmacological treatment for overactive bladder. J Urol
- : 168:1897-1913.
- Wein AJ. Neuromuscular dysfunction of lower urinary
- tract and its management. In: Walsh PC, Retik AB,
- Darracot Vaughan jr. E, Wein AJ (eds) Campell’s
- Urology. Saunders, Philadelphia, 2002: 931-1026.
- Madersbacher H, Rovner E. Trospium chloride: the
- European experience. Expert Opin Pharmacother 2006:
- :1373-1380.
- Hofner K, Oelke M, Machtens S, Grunewald T.
- Trospium chloride an effective drug in the treatment of
- overactive bladder and detrusor hyperreflexia. World J
- Urol 2001: 19: 336-343.
- Guay DR. Clinical pharmacokinetics of drugs used to
- treat urge incontinence. Clin Pharmacokinet 1986: 42:
- -1285.
- Vereecken RL. A critical view on the value of
- urodynamics in non neurogenic incontinence in women.
- Int Urogynecol J 2000: 11: 188-195.
- Coyne KS, Zyczynski T, Margolis MK, Elinof V,
- Roberts RG. Validation of an overactive bladder
- awareness tool for use in primary care settings. Adv
- Ther 2005: 22: 381-394.
- Hu TW, Wagner TH, Bentkover JD, et al. Estimated
- economic cost of overactive bladder in the United
- States. Urology 2003: 61: 1123-1128.
- Abrams P, Anderson KE. Muscarinic receptor
- anragonists for overactive bladder. BTU Int 2007: 100:
- -1006.
- Zinner M, Gittelman M, Haris R, et al. Trospium
- chloride improves bladder symptoms. A multicenter
- phase III trial. J Urol 2004:171: 2311-2315.
- Rudy D, Cline K, Harris R, et al.Multicenter phase III
- trial studying trospium chloride in patients with over
- active bladder. Urology 2006; 67:275-280.
- Halaska M, Ralph G, Wiedeman A, et al. Controlled,
- double-blind, multicenter clinical trial to investigate
- long-term tolerability and efficacy of trospium chloride
- in patients with detrusor instability. World J Urol 2002:
- : 392-399.
- Flisser A, Walmsey K, Blavias JG. Urodynamics
- classification of patients with symptoms of overactive
- bladder. J Urol 2003: 169: 529-533.
- Lin LY, Yeh NH, Lin CY, Sheu BC, Lin HH.
- Comparisons of urodynamic characteristics between
- female patients with overactive bladder and overactive
- bladder plus stress urinary incontinence. Urology 2004:
- : 945-949.
- Digesu GA, Khullar V, Cardozo L, Stefano S.
- Overactive bladder symptoms: Do we need
- urodynamics? Neurourol Urodyn 2003: 22: 105-108.
- Ouslander JG. Management of overactive bladder. N
- Engl J Med 2004: 350: 786-799.
- Staskin DR, Wein AJ, Andersson KE, et al. Overview
- consensus statement. Urology 2003: 61: 1128-8.
- Alloussi S, Laval KU, Eckert R, et al. Trospium chloride
- in patients with motor urge symptoms: A double blind,
- randomised, multicentre, placebo controlled study. J
- Drug Asses 1999: 2: 27-39.
There are 81 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Authors | |
| Publication Date | June 24, 2015 |
| IZ | https://izlik.org/JA76NW98AX |
| Published in Issue | Year 2008 Volume: 21 Issue: 2 |